Skip to Content

BCT 2 1/2 (Bromocriptine Mesylate 2.5 mg)

Pill with imprint BCT 2 1/2 is White, Round and has been identified as Bromocriptine Mesylate 2.5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Bromocriptine is used in the treatment of hyperprolactinemia; parkinson's disease; acromegaly; diabetes, type 2 and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BCT 2 1/2

Bromocriptine Mesylate

Imprint
BCT 2 1/2
Strength
2.5 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents, Prolactin inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-5325
Inactive Ingredients
silicon dioxide, corn starch, edetate disodium, lactose monohydrate, magnesium stearate, maleic acid, povidone

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.